These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27501236)

  • 21. Juvenile onset of primary low-grade cutaneous B-cell lymphoma.
    Amitay-Laish I; Feinmesser M; Ben-Amitai D; David M; Manor Y; Kidron D; Barzilai A; Hodak E
    Br J Dermatol; 2009 Jul; 161(1):140-7. PubMed ID: 19416255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric Primary Cutaneous Marginal Zone Lymphoma Treated With Doxycycline.
    Chan GC; Kamath S
    Cutis; 2023 Nov; 112(5):E1-E4. PubMed ID: 38091439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgG4 Expression in Primary Cutaneous Marginal Zone Lymphoma: A Multicenter Study.
    De Souza A; Ferry JA; Burghart DR; Tinguely M; Goyal A; Duncan LM; Kutzner H; Kempf W
    Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):462-467. PubMed ID: 28151793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary cutaneous marginal zone lymphoma (immunocytoma like) with lymphoepithelioid or Lennert's lymphoma like involvement of nodes.
    Shet T; Basak R; Epari S
    Indian J Pathol Microbiol; 2012; 55(2):222-6. PubMed ID: 22771649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete resolution of primary cutaneous marginal zone B-cell lymphoma on the cheek of a 7-year-old boy with intralesional triamcinolone and tincture of time.
    Skaljic M; Cotton CH; Reilly AF; Pillai V; Perman MJ
    Pediatr Dermatol; 2020 Jan; 37(1):228-229. PubMed ID: 31667886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Observation of lymphadenopathy, systemic symptoms, and treatment in suspected indolent cutaneous B-cell lymphomas.
    Puccio J; Huang Y; Viveiros MD; Reneau JC; Chung C; Spaccarelli N; Dulmage B
    Arch Dermatol Res; 2024 May; 316(5):199. PubMed ID: 38775835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High incidence of gastrointestinal tract disorders and autoimmunity in primary cutaneous marginal zone B-cell lymphomas.
    Guitart J; Deonizio J; Bloom T; Martinez-Escala ME; Kuzel TM; Gerami P; Kwasny M; Rosen ST
    JAMA Dermatol; 2014 Apr; 150(4):412-8. PubMed ID: 24500411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
    Palmedo G; Hantschke M; Rütten A; Mentzel T; Kempf W; Tomasini D; Kutzner H
    Am J Dermatopathol; 2007 Jun; 29(3):231-6. PubMed ID: 17519619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management.
    Wilcox RA
    Am J Hematol; 2015 Jan; 90(1):73-6. PubMed ID: 25535037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary cutaneous marginal zone B-cell lymphoma: clinical and histological aspects.
    Khaled A; Sassi S; Fazaa B; Ben Hassouna J; Ben Romdhane K; Kamoun MR
    Pathologica; 2009 Feb; 101(1):18-20. PubMed ID: 19771768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series.
    Fischbach W; Goebeler ME; Ruskone-Fourmestraux A; Wündisch T; Neubauer A; Raderer M; Savio A;
    Gut; 2007 Dec; 56(12):1685-7. PubMed ID: 17639089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-body positron emission tomography/computed tomography imaging and staging of orbital lymphoma.
    Roe RH; Finger PT; Kurli M; Tena LB; Iacob CE
    Ophthalmology; 2006 Oct; 113(10):1854-8. PubMed ID: 16860867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma.
    Peñate Y; Hernández-Machín B; Pérez-Méndez LI; Santiago F; Rosales B; Servitje O; Estrach T; Fernández-Guarino M; Calzado L; Acebo E; Gallardo F; Salar A; Izu R; Ortiz-Romero PL; Pujol RM; Fernández-de-Misa R
    Br J Dermatol; 2012 Jul; 167(1):174-9. PubMed ID: 22356294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and Management of Cutaneous B-cell Lymphoma.
    Pinter-Brown LC
    Dermatol Clin; 2015 Oct; 33(4):835-40. PubMed ID: 26433853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up and management of small and medium-sized CD4
    Virmani P; Jawed S; Myskowski PL; Horwitz S; Skripnik Lucas A; Moskowitz A; Pulitzer M; Zain J; Rosen ST; Querfeld C
    Int J Dermatol; 2016 Nov; 55(11):1248-1254. PubMed ID: 27369070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases.
    Kerl K; Prins C; Saurat JH; French LE
    Br J Dermatol; 2006 Dec; 155(6):1197-200. PubMed ID: 17107389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4 + Small/Medium T-Cell Lymphoproliferative Disorder : A Diagnostic Challenge Examined by Genomic Analysis.
    Obiorah IE; Karrs J; Brown L; Wang HW; Karai LJ; Pham TH; Pham TA; Xi L; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2023 Mar; 47(3):344-353. PubMed ID: 36598455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow involvement is rare in superficial gastric mucosa-associated lymphoid tissue lymphoma.
    Park JY; Kim SG; Kim JS; Jung HC
    Dig Liver Dis; 2016 Jan; 48(1):81-6. PubMed ID: 26548745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification.
    Suárez AL; Pulitzer M; Horwitz S; Moskowitz A; Querfeld C; Myskowski PL
    J Am Acad Dermatol; 2013 Sep; 69(3):329.e1-13; quiz 341-2. PubMed ID: 23957984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intra-lesional low-dose interferon alpha2a therapy for primary cutaneous marginal zone B-cell lymphoma.
    Cozzio A; Kempf W; Schmid-Meyer R; Gilliet M; Michaelis S; Schärer L; Burg G; Dummer R
    Leuk Lymphoma; 2006 May; 47(5):865-9. PubMed ID: 16753871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.